Randomized, Controlled Trial of Transdermal Clonidine for Smoking Cessation

Overview of attention for article published in Annals of Pharmacotherapy, September 1993

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

policy: 1 policy source

patent: 7 patents

Readers on

mendeley: 23 Mendeley

So far, Altmetric has seen 7 patents that reference this research output.

RECEPTOR-ADAPTED NICOTINE WITHDRAWAL BY ANTI-CHOLINERGIC AND ANTI-NORADRENERGIC BLOCKAGE

Application WO-2003015782-A3

World Intellectual Property Organisation (WIPO)

07 Aug 2003

Smoking cessation treatments using naltrexone and related compounds

Grant US-6541478-B1

United States of America

01 Apr 2003

RECEPTOR-ADAPTED NICOTINE WITHDRAWAL BY ANTI-CHOLINERGIC AND ANTI-NORADRENERGIC BLOCKAGE

Application WO-2003015782-A2

World Intellectual Property Organisation (WIPO)

27 Feb 2003

Smoking cessation treatments using naltrexone and related compounds

Grant US-6004970-A

United States of America

21 Dec 1999

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 3 additional patents.